G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-29
DOI
10.1038/s41416-020-01067-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Why randomized controlled trials do not always reflect reality
- (2019) Kosmas I. Paraskevas et al. JOURNAL OF VASCULAR SURGERY
- Stress granule: a promising target for cancer treatment
- (2019) Xiaomeng Gao et al. BRITISH JOURNAL OF PHARMACOLOGY
- G3BP1 promotes DNA binding and activation of cGAS
- (2018) Zhao-Shan Liu et al. NATURE IMMUNOLOGY
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Surgical management of advanced gastric cancer: An evolving issue
- (2016) L. Marano et al. EJSO
- Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Current adjuvant treatment modalities for gastric cancer: From history to the future
- (2016) Leyla Kilic et al. World Journal of Gastrointestinal Oncology
- Molecular mechanisms of chemoresistance in gastric cancer
- (2016) Wen-Jia Shi et al. World Journal of Gastrointestinal Oncology
- Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients
- (2015) Lingqiang Min et al. HISTOPATHOLOGY
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1
- (2014) N Oi et al. ONCOGENE
- Relationship between P53 Status and Response to Chemotherapy in Patients with Gastric Cancer: A Meta-Analysis
- (2014) Hai-Yuan Xu et al. PLoS One
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma
- (2013) Y Nishimura et al. BRITISH JOURNAL OF CANCER
- Chemotherapy for Advanced Gastric Cancer: Review and Update of Current Practices
- (2013) Sung Chul Park et al. Gut and Liver
- A randomized phase II trial of S-1-oxaliplatin versus capecitabine–oxaliplatin in advanced gastric cancer
- (2012) Gun Min Kim et al. EUROPEAN JOURNAL OF CANCER
- Stress Granules Inhibit Apoptosis by Reducing Reactive Oxygen Species Production
- (2012) M. Takahashi et al. MOLECULAR AND CELLULAR BIOLOGY
- Meta-analysis of the expression of the mitosis-related gene Fam83D
- (2012) LOKMAN VARISLI Oncology Letters
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram
- (2010) Vivian E. Strong et al. ANNALS OF SURGERY
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
- (2009) M. H. Kang et al. CLINICAL CANCER RESEARCH
- Eukaryotic Stress Granules: The Ins and Outs of Translation
- (2009) J. Ross Buchan et al. MOLECULAR CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started